Page last updated: 2024-12-07
lipoyl-4-aminobenzoic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
lipoyl-4-aminobenzoic acid: biotinidase substrate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 125390 |
| CHEMBL ID | 3099568 |
| SCHEMBL ID | 8521070 |
| MeSH ID | M0181686 |
Synonyms (10)
| Synonym |
|---|
| lipoyl-4-aminobenzoic acid |
| 4-[5-[(3r)-dithiolan-3-yl]pentanoylamino]benzoic acid |
| 129706-46-3 |
| lipoyl-p-aminobenzoate |
| benzoic acid, 4-((5-(1,2-dithiolan-3-yl)-1-oxopentyl)amino)-, (r)- |
| l-paba |
| CHEMBL3099568 |
| SCHEMBL8521070 |
| DTXSID70926465 |
| 4-{[5-(1,2-dithiolan-3-yl)pentanoyl]amino}benzoic acid |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (1)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1061203 | Cardioprotective activity in Sprague-Dawley rat model of myocardial ischemia-reperfusion injury assessed as reduction in MI/AR ratio at 1 to 10 mg/kg, iv bolus administered 15 mins prior to 30 mins LCX ligation by TTC staining-based fluorescence microscop | 2014 | Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1 | Lipoic acid analogs with enhanced pharmacological activity. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.53
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.53) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||